The Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Valued at USD 31.14 billion in 2026, the global market is projected to expand at a robust compound annual growth rate (CAGR) of 6.25% over the forecast period, reaching an estimated USD 50.57 billion by 2034.
The global respiratory therapeutics landscape is experiencing a paradigm shift. For decades, the chronic obstructive...
